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Daunorubicin aqueous solutions were reduced by COO- free radicals produced by y-radiolysis. This 
reaction leads to 7-deoxyaglycon daunomycinone. Added before irradiation, Hz02 oxidizes hydroquinone 
daunorubicin giving back the drug directly and thus preventing C-O bond cleavage. The implications of 
this reaction on the mechanism of the reductive cleavage are discussed. 
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1. INTRODUCTION 
Daunorubicin (daunomycin) (fig.l), one of the 
anthracycline antitumour antibiotics, is widely 
used in cancer chemotherapy. It is generally be- 
lieved that this antibiotic is activated by electron 
transfer to provide semiquinone and/or hydro- 
quinone reduced states [ 11. One of these forms or 
both is able to lose its sugar moiety under 
anaerobic conditions [2]. The resulting aglycon has 
been isolated after in vivo or in vitro reduction 
(e.g., [31). 
RhBne-Poulenc Normapur products. N20 was a 
CFPO product. Water was triply distilled and its 
purity controlled by conductivity measurements 
(< 10m6 0-l -cm-‘). All the vessels for irradiation 
were cleaned after washing by heating at 400°C for 
3-4 h. 
y-Irradiations were made in a ?Jo irradiator. 
c F! QH OH OH 
This study concerns two main points: (i) the 
reductive glycosidic bond cleavage mechanism and 
(ii) Hz02 reactions with the transient reduced 
forms of daunorubicin. These reactions are poorly 
understood although they might play a role in 
daunorubicin toxicity during lipid peroxidation in 
vivo. 
2. MATERIALS AND METHODS 
Daunorubicin-HCl was purchased from Sigma. 
Daunomycinone was donated by RhBne-Poulenc. 
Reagents (NaH2P04, NaHCO3, NaOH) were 
Fig. 1. Structure of daunorubicin (DOS), hydroquinone 
daunorubicin (DHzOS) and 7-deoxyaglycon daunomy- 
cinone (DH). D denotes the anthraquinone part and S 
the amino sugar. These symbols have no acido-basic 
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Its dosimetry was determined by Fricke’s method 
taking G = 15.6 molecules/100 eV and ~~4 = 
2160 mol-‘.l.crn-‘. The doses were delivered at a 
rate of -3 x 1017 eV.cme3. h-’ and varied bet- 
ween 10” and 3 x 10” eV.cmm3. Irradiated solu- 
tions were transferred to the absorption cell under 
deaerated atmosphere to avoid eventual reoxida- 
tion. 
To identify the precipitate, the irradiated solu- 
tions were centrifuged. The precipitate was washed 
several times with distilled water and dried. The 
NMR analysis was made in the ESCOM NMR ser- 
vice using a Briicker WP 80 device. 
3. RESULTS 
3.1. Irradiations 
Daunorubicin (DOS) aqueous solutions (pH 7, 
phosphate buffer 6 x 10v2 mol.l-‘, [DOS], bet- 
ween 2 x 10e5 and 3.6 x 10m4 mol. 1-l) were ir- 
radiated in the presence of sodium formate 
(0.1 mol. 1-l) and under an atmosphere of N20 to 
transform e&, into OH’ radicals. H’ and OH’ 
radicals reacted with HCOO- to produce COO’- 
free radicals. Thus the only species which could 
react with DOS were COO- reducing ions and 
their yield of formation was equal to: 
G(CO0’ -) = 
GH + GOH + G, = 6 molecules/l00 eV 
Fig.2 shows the absorption spectra of some ir- 
radiated solutions for [DOS], = 1.52 x 
10e4 mol. 1-l. When the dose increases the max- 
imum at 480-500 nm decreases and the absorption 
at 56-750 nm increases slightly. For doses c 1 x 
lo’* eV.cmw3 these spectra can be normalized to 
the DOS spectrum. For higher doses there is a dif- 
ference of 10% between the experimental and nor- 
malized spectra (fig.2d) at h < 440 nm and h > 
540 nm. These spectra are not modified by air en- 
trv after irradiation. 
For doses higher than -1 x lo’* eV. cmm3, a red 
powder precipitates. NMR analysis of this 
precipitate was performed. The whole spectrum 
was compared to the daunomycinone NMR spec- 
trum and could be attributed to 7-deoxyaglycon 
daunomycinone (DH) (see fig. 1 for DH structure). 
DH solubility in water is -lo-’ mol. l-‘, perhaps 
slightly higher in DOS solutions. For such concen- 
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Fig.2. Absorption spectra of daunorubicin irradiated 
aqueous solutions. [DOS] = 1.52 x 10m4 M, 
[HCOO-] = 0.1 M, pH 7, phosphate buffer 6 x 
10v2 M, N20. Curves: (a) no irradiation, initial solution; 
(b) 3.78 x 10” eV.cme3; (c) 1.026 x 10” eV .crnw3; (d) 
2.08 x lo’* eV . cmm3, ( + ) D-OS spectrum normalized at 
480 nm. 
trations, DH contribution to the absorption spec- 
tra is negligible. In particular, the absorption at 
560-750 nm does not belong to DH and is not due 
to Hz02 reactions (see section 3.2). It may belong 
to another reduced form of the drug which would 
represent only a few percent of [DOS],. This was 
demonstrated by comparison of the weight of 
precipitate and the amount of disappeared DOS. 
This amount of disappeared drug [DOS]di, was 
calculated at 480 nm (6480 = 10450 mol-' .l *cm-‘) 
(e.g., see fig.3a). [DOS]dis is proportional to the 
dose. The slope of the straight line is equal to 
G( - DOS) = 2.30 + 0.10 molecules/l00 eV and is 
independent of [DOS],, (inset, fig.3). G( - DOS) is 
very close to 
G(CO0’ -) 6 
2 
- GH~o~ = 
z- 0e7 = 
2.3 molecules/l00 eV 
This means that DOS is reduced with two 
equivalents and that Hz02 produced radiolytically 
reoxidizes a reduced form of DOS giving back the 
initial drug. 
3.2. Action of Hz02 
To determine which 
tacked by Hz02 and the 
compound(s) is/are at- 
mechanism of this oxida- 
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Fig.3. DOS disappearance on irradiation. [DOS],, = 
8.85 x lo-’ M, [HCOO-I = 0.1 M, pH 7, phosphate 
buffer 6 x lo-’ M, N20, dose rate -3 x 10” eV.cm-3. 
(a) No added HzOz, (b) [HzO& = 5 x lo-’ M, (c) 
D-I20210 = 2 x 10m4 M. (inset) Variation of G( - DOS) 
with [DOS-Jo. 
tion, the reactions of Hz02 during and after ir- 
radiation were studied. The initial antibiotic does 
not react with H202. 
3.2.1. After irradiation 
Addition of Hz02 after irradiation led to no 
change in the absorption spectrum, amount of 
precipitate and G( - DOS), showing that H202 
does not react after irradiation. 
3.2.2. During irradiation 
DOS aqueous solutions identical to the 
Fig.4. A proposed mechanism for hydroquinone 
daunorubicin oxidation by H202. 
preceding ones were irradiated in the presence of 
various H202 initial concentrations from 5 x lo-’ 
to 2 X lo-* mol.l-’ (see fig.3b,c). [DOS]dis is pro- 
portional to the dose but G(-DOS) decreases 
when Hz02 increases. The minimal dose for the 
beginning of precipitation increases with [H20210. 
As an example, for [H20& = 2 x lo-* mol.l-‘, 
precipitation begins at doses -2 x 1018 eV - cme3. 
So it seems that Hz02 reacts with an intermediate 
reduced form of DOS, thus delaying precipitation. 
4. DISCUSSION 
4.1. Reactions of COO’ - 
The kinetic scheme for COO’- reactions may be 
written: 
DOS + COO’- - DOS’- + CO2 (1) 
DOS’- + CO;- 2H: DH2OS + CO2 and/or (2) 
2DOS’- 2H+ - DOS + DHzOS (3) 
DOS’- and DH2OS represent he semiquinone 
and the hydroquinone forms of daunorubicin, 
respectively. COO’- disproportionation does not 
occur here since G( -DOS) is independent of 
[DOS]O, which means that all COO’- react with 
the drug. 
4.2. DH precipitation 
According to the literature, this can occur by: 
DOS’- E’ DHl + SO’ or D’ + SOH and/or (4) 
DHzOS = DHl + SOH (5) 
It is known that the hydroquinone drug is 
unstable. Under the conditions of y-radiolysis 
reaction 4 does not proceed because it would lead 
to G( - DOS) = 6 molecules/100 eV. So, during y- 
radiolysis, C-O bond cleavage occurs on the hydro- 
quinone form DHzOS, the concentration of which 
is at a steady state. 
4.3. Reactions of HZOZ 
It was seen that G( - DOS) = [G(COO’-)/2] - 
GH~o~ which indicated that Hz02 was responsible 
for a reverse reaction. As this reaction gives back 
DOS, it must concern a compound still possessing 
its sugar. It was proposed recently [4-61: 
DOS’- + Hz02 - DOS + OH’ + OH- (6) 
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Similarly, one can suppose: 
DHzOS + H202 - 
DOS’- + OH’ + OH- + 2H+ (7) 
However, with some hydroquinonic com- 
pounds, a direct two-electron oxidation by Hz02 
may be encountered [7]: 
DHzOS + H202 - DOS + 2H20 (8) 
Since HCOO- ions are in excess, reactions 6 and 
7 would be followed by: 
OH’ + HCOO- - H20 + COO’- (9) 
giving a reducing COO’- and G( - DOS) would be 
equal to G(COO’-)/2 = 3 molecules/l00 eV. To 
explain the lower experimental value, reaction 8 
leading directly from DH20S to DOS has to occur. 
It also means that under the condition of y- 
radiolysis, reactions 6 and 7 do not occur. Fig.4 
shows a proposed mechanism. 
Calculation of G( - DOS) from the kinetic 
scheme of reactions l-3,5 and 8 leads to: 
G( - DOS) = G(CO0’ -) (1 - ’ ks ) 
1+ 
ks [Hz021 
Knowing G( - DOS) for different [H20&, 
was evaluated: 
kdka 
$ = (3.3 f 0.7) x 10-j mol.l-’ 
4.4. Mechanism of the glycosidic bond cleavage 
Reaction 5 can proceed by two different 
mechanisms, heterolytic or homolytic elimination 
[8]. Homolytic breakage would lead to hydro- 
quinone 7-deoxydaunomycinone by radical 
disproportionation. This compound has never 
been found in our irradiated solutions. So our 
results seem to favour heterolytic C-O bond 
cleavage, at least for the major process. 
In conclusion, this work demonstrates that when 
daunorubicin is reduced by COO’- during y- 
radiolysis: (i) the C-O bond cleavage occurs on the 
hydroquinone compound and probably has a 
heterolytic mechanism and (ii) Hz02 oxidizes 
hydroquinone daunorubicin (DH20S) giving in 
one step the quinone form. This reaction should be 
taken into account in the mechanism of cardiotox- 
icity and of lipid peroxidation induced by this 
antibiotic. 
ACKNOWLEDGEMENTS 
We are indebted to Dr Lavelle (Rhone-Poulenc) 
for samples of daunorubicin and daunomycinone 
and for his encouragement. We thank D. Jore, the 
NMR Service of ESCOM and F. Drisch for the 
NMR analysis. We wish to thank A. Rouscilles for 
her excellent technical assistance. 
REFERENCES 
111 
121 
t31 
[41 
VI 
[61 
171 
PI 
Bachur, N.R., Gordon, S.L. and Gee, M.V. (1977) 
Mol. Pharmacol. 13, 901-910. 
Bachur, N.R., Gordon, S.L. and Gee, M.V. (1978) 
Cancer Res. 38, 1745-1750. 
Arcamone, F. (198 1) Doxorubicin Anticancer 
Antibiotics, pp.141-142, Academic Press, New 
York. 
Winterbourn, C.C. (1981) FEBS Lett. 136, 89-94. 
Bates, D.A. and Winterbourn, C.C. (1982) FEBS 
Lett. 145, 137-142. 
Nohl, H. and Jordan, W. (1983) Biochem. Biophys. 
Res. Commun. 114, 197-205. 
Houte-Levin, C., Gardb-Albert, M., Ferradini, C. 
and Pucheault, J. (1980) Radiat. Res. 83, 270-278. 
Fisher, J., Ramakrishnan, K. and Becvar, J.E. 
(1983) Biochemistry 22, 1347-1355. 
30 
